| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |